Nothing Special   »   [go: up one dir, main page]

Siapati et al., 2011 - Google Patents

Proliferation and bone marrow engraftment of AML blasts is dependent on β‐catenin signalling

Siapati et al., 2011

Document ID
14748192419931928177
Author
Siapati E
Papadaki M
Kozaou Z
Rouka E
Michali E
Savvidou I
Gogos D
Kyriakou D
Anagnostopoulos N
Vassilopoulos G
Publication year
Publication venue
British journal of haematology

External Links

Snippet

B‐catenin is the central effector molecule of the canonical Wnt signalling pathway, which controls self‐renewal of haematopoietic stem cells. Deregulation of this pathway occurs in various malignancies including myeloid leukaemias. The present study examined the …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells

Similar Documents

Publication Publication Date Title
Mouton et al. Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis
Siapati et al. Proliferation and bone marrow engraftment of AML blasts is dependent on β‐catenin signalling
Ibrahim et al. Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling
Choi et al. Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization
Yumoto et al. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
Zhang et al. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment
Dubrovska et al. CXCR4 expression in prostate cancer progenitor cells
Mao et al. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia
Wilson et al. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity
Li et al. A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma
Salazar et al. The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation
Kaucká et al. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration
Shaham et al. MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome
Mukhopadhyay et al. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells
US10017767B2 (en) Targets in multiple myeloma and other disorders
Zhang et al. Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression
Bam et al. Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease
Rothe et al. Integrin-linked kinase mediates therapeutic resistance of quiescent CML stem cells to tyrosine kinase inhibitors
Kohsaka et al. Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma
Yan et al. Neural cell adhesion protein CNTN1 promotes the metastatic progression of prostate cancer
Mougiakakos et al. The IKZF1–IRF4/IRF5 axis controls polarization of myeloma-associated macrophages
Seol et al. Overexpression of CD99 increases the migration and invasiveness of human malignant glioma cells
Satcher et al. Cadherin-11 in renal cell carcinoma bone metastasis
Lee et al. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo
López-Guerra et al. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells